DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Avastin (Bevacizumab) - Current Clinical Trials

 
 



Avastin Related Clinical Trials

A Phase 2 Evaluation of Anti-VEGF Therapy for Diabetic Macular Edema: Bevacizumab (Avastin) [Completed]

Safety Study Of Avastin And Pelvic Radiation In Women With Recurrent Gynecological Cancers [Completed]

Safety/Biomarker Study of CNTO 95 and Avastin in Solid Tumors [Completed]

Dose-Escalation Study of TPI 287 + Avastin Followed by Randomized Study of the Same Versus Avastin for Glioblastoma [Recruiting]

Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian Cancer [Active, not recruiting]

Phase I - Pharmacokinetic Comparability Study in Healthy Male Volunteers [Active, not recruiting]

Lower Dose Chemotherapy Given More Frequent With Avastin to Treat Advanced Non-Squamous Non-Small Cell Lung Cancer [Active, not recruiting]

Neuradiab« Combined With Bevacizumab (Avastin) Therapy in Patients With Recurrent Glioblastoma Multiforme [Not yet recruiting]

Phase II Pilot Study of Visudyne´┐Ż Photodynamic Therapy (PDT) (Low and Very Low Fluence) Combined With Bevacizumab. [Completed]

Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian Cancer [Terminated]

Avastin in Combination With Temozolomide for Unresectable or Multifocal GBMs and Gliosarcomas [Completed]

Safety & Efficacy Study of TPI 287 + Avastin in Adults With Glioblastoma That Progressed Following Prior Avastin Therapy [Recruiting]

Avastin/Temozolomide/Irinotecan for Unresectable/Multifocal Glioblastoma Multiforme [Completed]

A Phase II Safety and Tolerability Study of Bevacizumab When Added to Single-agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to Brain [Terminated]

Combination Therapy for Age-Related Macular Degeneration. [Completed]

Bevacizumab, Temsirolimus, Valproic Acid, Cetuximab [Recruiting]

Gliadel, XRT, Temodar, Avastin Followed by Avastin, Temodar for Newly Diagnosed Glioblastoma Multiforme (GBM) [Active, not recruiting]

AMG 102 and Avastin for Recurrent Malignant Glioma [Active, not recruiting]

Bevacizumab Plus Ipilimumab in Patients With Unresectable Stage III or IV Melanoma [Active, not recruiting]

A Safety and Efficacy Study of BCD-021 With Paclitaxel and Carboplatin Compared to Avastin With Paclitaxel and Carboplatin in Non-Small Cell Lung Cancer [Active, not recruiting]

Neoadjuvant Chemoradiation With RHUMAB VEGF (Avastin) for Rectal Cancer [Completed]

Phase II Study of Bevacizumab (Avastin«) in Myelofibrosis [Terminated]

Bevacizumab Versus Bevacizumab Plus Vorinostat in Adults With Recurrent Glioblastoma [Active, not recruiting]

Avastin (Bevacizumab) and RAD001 (Everolimus) in Advanced Low or Intermediate Grade Neuroendocrine Carcinoma [Completed]

Efficacy Study of Avastin« With Pemetrexed +/- Carboplatin to Treat Elderly Patients With Non-small Cell Lung Cancer [Completed]

Avastin Plus Rituximab for Patients With B-Cell Non-Hodgkin's Lymphoma [Completed]

Avastin and Chemotherapy Followed by a KRAS Stratified Randomization to Maintenance Treatment for First Line Treatment of Metastatic Colorectal Cancer. [Completed]

Intraperitoneal Paclitaxel and Carboplatin With IV Avastin Therapy in Patients With Carcinomas of Mullerian Origin [Active, not recruiting]

Intravitreal Avastin in Proliferative Retinopathies [Completed]

Neoadjuvant Chemotherapy With Methotrexate, Vinblastine, Adriamycin and Cisplatin (M-VAC) Plus Avastin in Patients With Urothelial Cancer [Completed]

Randomized Controlled Trial of Subconjunctival Bevacizumab Injection in Impending Recurrent Pterygium [Completed]

Avastin/Docetaxel/Carboplatin in Non-Small Cell Lung Cancer [Active, not recruiting]

Pharmacokinetic Study of Avastin and Doxil in Ovarian Cancer [Completed]

Avastin for PDR (Proliferative Diabetic Retinopathy) [Completed]

Radiosensitization of AVASTIN« (Bevacizumab) With Stereotactic Body Radiotherapy for Colorectal Liver Metastasis [Completed]

Avastin/FOLFIRI in Combination With Curcumin in Colorectal Cancer Patients With Unresectable Metastasis [Not yet recruiting]

Bevacizumab, Erlotinib and Capecitabine for Advanced Pancreatic Cancer [Completed]

Avastin as an Adjunct to Diode Laser in the Treatment of Neovascular Glaucoma [Completed]

Avastin in Combination With Radiation (XRT) & Temozolomide, Followed by Avastin, Temozolomide and Irinotecan for Glioblastoma (GBM) and Gliosarcomas [Completed]

Intraocular Bevacizumab Compared With Intraocular Triamcinolone in Patients With Diabetic Macular Edema [Recruiting]

Phase II Avastin + Bortezomib for Patients With Recurrent Malignant Glioma [Completed]

Randomized Phase III Study of Folfiri+Avastin Versus Xeliri+Avastin as 1st Line Treatment of CRC [Completed]

Treatment With Intravitreal Avastin for Large Uveal Melanomas [Completed]

Does Adding Bevacizumab Therapy in Glaucoma Surgery Improve the Success of Needle Bleb Revisions? [Completed]

Results of Adjunctive Intraoperative Bevacizumab Injection on Trabeculectomy Outcome [Completed]

Intralesional Bevacizumab Injection on Primary Pterygium [Recruiting]

Safety and Effectiveness of Bevacizumab Intravitreal Injections in the Treatment of Macular Edema Secondary to Retinal Vein Occlusion [Completed]

Study of Avastin (Bevacizumab) to Reverse Acquired Estrogen Independence in Previously Hormone Responsive Metastatic Breast Ca. [Completed]

A Study of Gliadel Followed by Avastin + Irinotecan for Glioblastoma Multiforme (GBM) [Terminated]

NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma [Recruiting]

Bevacizumab and Trabectedin +/- Carboplatin in Advanced Ovarian Cancer [Recruiting]

HAI Abraxane With Gemcitabine and Bevacizumab [Completed]

Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma [Completed]

Bevacizumab Plus Modified FOLFOX6 Regimen as the Salvage Treatment in Metastatic Breast Cancer (MBC) Patients [Active, not recruiting]

Bioequivalence Study Bevacizumab Biosimilar (BEVZ92) Versus Bevacizumab (AVASTIN«) in First-line Treatment mCRC Patients [Recruiting]

Safety Study of Avastin Used as Adjunctive Therapy in Pterygium Surgery [Active, not recruiting]

Avastin/Radiation (XRT)/Temozolomide (Temodar) Followed by Avastin/Temodar/Topotecan for Glioblastoma [Active, not recruiting]

Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, Leucovorin, and Avastin [Completed]

Bevacizumab Plus Irinotecan Plus Carboplatin for Recurrent Malignant Glioma (MG) [Completed]

Ph II Bev + Either Temozolomide/Etoposide for GBM Pts Who Have Failed Bev + Irinotecan [Completed]

A Study of Subcutaneous Bevacizumab in Relapsed / Progressive Glioblastoma [Recruiting]

A Phase 3 Safety and Efficacy Study of Fovista« (E10030) Intravitreous Administration in Combination With Either Avastin« or Eylea« Compared to Avastin« or Eylea« Monotherapy [Recruiting]

Study of TRC105 Combined With Standard-Dose Bevacizumab for Advanced Solid Tumors for Which Bevacizumab is Indicated [Completed]

Randomized Phase II Study of Preoperative Letrozole (Femara) in Combination With Avastin in Hormone Receptor Positive Breast Cancer [Recruiting]

Erlotinib and Avastin in Patients With Cancer of the Esophagus or Gastroesophageal Junction [Terminated]

Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma [Active, not recruiting]

Safety & Efficacy of Three Docetaxel-Based Chemotherapy Regimens Plus Bevacizumab With or Without Trastuzumab for Adjuvant Treatment of Patients With Breast Cancer [Completed]

Prospective Randomized Trial of Proton Beam Combined With Anti-VEGF Therapy for Exudative Age-related Macular Degeneration (AMD) [Recruiting]

Bevacizumab 0.500MG Intravitreal There Isn't Lower Than 0.625MG in the Treatment of ROP Type 1 [Recruiting]

Safety Study of Bevacizumab (Avastin) With Thoracic Radiation in Non-small Cell Cell Lung Cancer [Terminated]

Bevacizumab and Temozolomide Following Radiation and Chemotherapy for Newly Diagnosed Glioblastoma Multiforme [Active, not recruiting]

Efficacy Study of Triamcinolone and Bevacizumab Intravitreal for Treatment of Diabetic Macular Edema [Recruiting]

Phase 1/2 CTO + Bevacizumab for Recurrent Glioma Post-Bevacizumab Failure [Suspended]

Valproic Acid and Bevacizumab in Patients With Advanced Cancer [Completed]

Avastin in Patients With Epithelial Ovarian, Primary Peritoneal Serous or Fallopian Tube Cancer [Terminated]

Phase I/II Bevacizumab Versus Bevacizumab Plus TPI 287 for Recurrent Glioblastoma [Active, not recruiting]

Preoperative Chemotherapy and Bevacizumab in Patients With Stage IB (>4 cm), II, or Select Stage III NSCLC [Terminated]

Bevacizumab and BKM-120 in Patients With Metastatic Renal Cell Carcinoma [Active, not recruiting]

Intraarterial Cerebral Infusion of Avastin for Vestibular Schwannoma (Acoustic Neuroma) [Recruiting]

Bevacizumab in Combination With Metronomic Temozolomide for Recurrent Malignant Glioma [Completed]

Cisplatin/Vinorelbine/Bevacizumab Followed by Docetaxel/Gemcitabine/Bevacizumab Versus the Cisplatin/Docetaxel/Bevacizumab Combination in Locally Advanced or Metastatic NSCLC [Completed]

Hepatic Arterial Infusion Oxaliplatin, Capecitabine With or Without Bevacizumab [Active, not recruiting]

Intranasal Bevacizumab for HHT-Related Epistaxis [Recruiting]

Nivolumab vs Nivolumab + Bevacizumab vs Nivolumab + Ipilimumab in Metastatic Renal Cell Carcinoma (mRCC) [Recruiting]

Trial of Paclitaxel/Bevacizumab +/- Everolimus for Patients With HER2-Negative Metastatic Breast Cancer [Completed]

Erlotinib Plus Bevacizumab in Hepatocellular Carcinoma (HCC) as Second-line Therapy [Active, not recruiting]

Dasatinib, Bevacizumab, Paclitaxel in Patients With Advanced Malignancies [Active, not recruiting]

Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Patients With Hepatocellular Carcinoma [Completed]

A Study of Avastin (Bevacizumab) in Combination Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum [Completed]

Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM) [Active, not recruiting]

Trial of Chemotherapy and Avastin as Treatment for Women With Breast Cancer at High Risk for Relapse [Terminated]

Hepatic Arterial Infusion Oxaliplatin + 5FU, Leucovorin, and Bevacizumab +/- Cetuximab [Completed]

Phase II Study of Avastin + Erbitux + Irinotecan as 2nd Line Treatment of Colorectal Cancer [Terminated]

Bevacizumab in Treating Patients With Angiosarcoma [Active, not recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015